Correspondence 0001213900-25-073861 from Papa Medical Inc. (PAPA) (CIK 0002024283) (PAPA)
Papa Medical Inc. (PAPA) (CIK 0002024283)
Date: Aug. 8, 2025 · CIK: 0002024283 · Accession: 0001213900-25-073861
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-283405
Letter
Re:
August 8, 2025
VIA EDGAR
Securities and Exchange Commission Division of Corporation Finance
Office of Manufacturing
100 F Street, N.E. Washington, D.C. 20549
Attention: Kevin Stertzel, Kevin Woody, Eranga Dias and Jay Ingram
Papa Medical Inc. (CIK No. 0002024283) Registration Statement on Form S-1, as amended Initially Filed on November 22, 2024 File No. 333-283405
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the "Act"), the undersigned hereby joins in the request of Papa Medical Inc. that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 10:00 a.m., Eastern Time, on August 12, 2025, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Loeb & Loeb LLP, request by telephone that such Registration Statement be declared effective.
Pursuant to Rule 460 of the General Rules and Regulations of the Securities and Exchange Commission under the Securities Act of 1933, as amended, please be advised that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
[ Signature Page Follows ]
Very truly yours,
US TIGER SECURITIES
Show Raw Text
CORRESP 1 filename1.htm August 8, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Manufacturing 100 F Street, N.E. Washington, D.C. 20549 Attention: Kevin Stertzel, Kevin Woody, Eranga Dias and Jay Ingram Re: Papa Medical Inc. (CIK No. 0002024283) Registration Statement on Form S-1, as amended Initially Filed on November 22, 2024 File No. 333-283405 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the "Act"), the undersigned hereby joins in the request of Papa Medical Inc. that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 10:00 a.m., Eastern Time, on August 12, 2025, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Loeb & Loeb LLP, request by telephone that such Registration Statement be declared effective. Pursuant to Rule 460 of the General Rules and Regulations of the Securities and Exchange Commission under the Securities Act of 1933, as amended, please be advised that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus. The undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. [ Signature Page Follows ] Very truly yours, US TIGER SECURITIES By: /s/ Jack Ye Name: Jack Ye Title: Managing Director [ Signature Page to Underwriter's Acceleration Request Letter ]